NSEAcquisition30 Jun 2026 · 30 Jun 2026, 09:57 am
Acquisition
Aurobindo Pharma Limited · AUROPHARMA
✦ AI Summary▲ PositiveM&A
Aurobindo Pharma Limited has completed the acquisition of Lannett Company, Inc. through its US subsidiary, Aurobindo Pharma USA Inc.
Analysis Scores
Earnings Impact6/10
Growth Catalyst8/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment8/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Intimation of completion of Lannett acquisition by Aurobindo Pharma USA Inc., a wholly owned subsidiary of the Company.
Attachments (1)
📄pdf
Download →
AUROPHARMA_30062026095710_LtrToSEsLannettAcquistionCompletion30062026.pdf
View document text
June 30, 2026
To To
Listing Department, The Corporate Relations Department
NATIONAL STOCK EXCHANGE OF INDIA LIMITED BSE LIMITED
Exchange Plaza, Bandra Kurla Complex, Bandra (E), Phiroz Jeejeebhoy Towers, 25th floor, Dalal
MUMBAI -400 051 Street, MUMBAI -400 001
Company Code No. AUROPHARMA Company Code No. 524804
Dear Sir / Madam,
Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements)
Regulations, 2015.
Ref: Our letter dated June 19, 2026, and press release dated June 22, 2026
Aurobindo Pharma USA Inc., (APUSA), a wholly owned subsidiary of Aurobindo Pharma Limited, is pleased to
announce the successful completion of its acquisition of Lannett Company, Inc., USA (“Lannett”), from
Lannett Seller Holdco, Inc., following receipt of approval from the U.S. Federal Trade Commission on June 18,
2026.
Effective June 29, 2026, Lannett has become a wholly owned subsidiary of APUSA and will operate as Lannett
Company LLC.
The integration process will commence immediately, with a strong emphasis on ensuring uninterrupted
access to critical medications, maintaining trusted relationships with partners, and supporting employees
throughout the transition. By combining capabilities and resources, the organization aims to enhance the
availability of essential medicines and deliver sustained, long-term value to patients, customers, and
stakeholders.
APUSA is also pleased to welcome more than 400 Lannett employees to its organization, further strengthening
its talent base and operational capabilities.
We extend our sincere appreciation to Lannett’s management team for their leadership in enabling a smooth
transition, as well as for their valuable contributions to the organization.
Please take the above information on record.
Yours faithfully,
For AUROBINDO PHARMA LIMITED
B. Adi Reddy
Company Secretary
Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India.
Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044.
Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038, Telangana., India. Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833
Email: info@aurobindo.com Website: www.aurobindo.com